P
Patrick C. Y. Woo
Researcher at Li Ka Shing Faculty of Medicine, University of Hong Kong
Publications - 621
Citations - 37320
Patrick C. Y. Woo is an academic researcher from Li Ka Shing Faculty of Medicine, University of Hong Kong. The author has contributed to research in topics: Coronavirus & Gene. The author has an hindex of 85, co-authored 593 publications receiving 31877 citations. Previous affiliations of Patrick C. Y. Woo include The Chinese University of Hong Kong & Kwong Wah Hospital.
Papers
More filters
Journal ArticleDOI
Bats as a continuing source of emerging infections in humans
TL;DR: Cross‐infection between the huge number of bat species may generate new viruses which are able to jump the trans‐mammalian species barrier more efficiently, and the risks of transmission to humans are highlighted.
Journal ArticleDOI
Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients.
V. C. C. Cheng,Pak-Leung Ho,Rodney A. Lee,K. S. Chan,K. K. Chan,Patrick C. Y. Woo,Susanna K. P. Lau,Kwok-Yung Yuen +7 more
TL;DR: A surge in the lymphocyte count, accompanied by an exaggerated tuberculin skin reaction, was observed in the authors' patients during the paradoxical deterioration, analogous to the findings in HIV-positive patients.
Journal ArticleDOI
Molecular diversity of coronaviruses in bats.
Patrick C. Y. Woo,Susanna K. P. Lau,Kenneth S. M. Li,Rosana W.S. Poon,Beatrice H.L. Wong,Hoi Wah Tsoi,Bethanie C.K. Yip,Yi Huang,Kwok-Hung Chan,Kwok-Yung Yuen +9 more
TL;DR: Phylogenetic analysis of RNA-dependent-RNA-polymerase (pol) and helicase genes revealed six novel coronaviruses from six different bat species, in addition to the two previously described coronavirus in bats.
Journal ArticleDOI
Global Epidemiology of Bat Coronaviruses.
TL;DR: This article aims at reviewing the various aspects of the global epidemiology of bat coronaviruses (CoVs) and suggests that alphaCoVs seem to be more widespread than betaCoVs, and their detection rate is also higher.
Journal ArticleDOI
Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients.
TL;DR: It is demonstrated that rapid diagnosis of respiratory viral infections in children is a cost-effective procedure and significantly reduced hospital stays, antibiotic use, and laboratory utilization.